Physician profile
Bari Eichelbaum
NPI 1811469471
$3,820.26
in general payments reported to CMS, 2019-2025
13 companies · $3,146 in 2025
The $3,146 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $148 · 2022: $294 · 2023: $189 · 2024: $43.96 · 2025: $3,146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,530 · Food and Beverage: $848.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,530.44 |
| Food and Beverage | $848.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,655.76 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $1,316.54 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $310.76 | 2023-2025 | Airsupra, Breztri, Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $168.68 | 2021-2022 | |
| Boston Scientific Corporation | $112.72 | 2024-2025 | Varithena Administration Pack |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.86 | 2021-2022 | |
| Novo Nordisk INC | $44.66 | 2021-2022 | |
| Genentech USA, INC. | $39.45 | 2021-2022 | |
| Abbvie INC. | $38.43 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $18.37 | 2022 | |
| Lilly USA, LLC | $17.85 | 2021 | |
| Eisai INC. | $14.98 | 2021 | |
| Esperion Therapeutics, INC. | $11.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bari Eichelbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.